2010
DOI: 10.3892/or_00000853
|View full text |Cite
|
Sign up to set email alerts
|

MEK1 and MEK2 isoforms regulate distinct functions in pancreatic cancer cells

Abstract: Abstract. The mitogen-activated protein kinase kinase 1/2 (MEK1/2) signalling pathway plays a central role in tumour progression. Small molecules that inhibit MEK1/2 are therefore considered attractive candidates for anti-cancer drugs. However, the exact contributions of MEK1 and MEK2 to the development of pancreatic cancer remain to be established. To differentiate the functions of MEK1 and MEK2 in a cultured pancreatic cancer cell line, we utilised shRNAmediated knockdown of their two mRNAs individually. We … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
references
References 16 publications
0
0
0
Order By: Relevance